Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity

Bibliography

• Gutman S, Hackett J. Search for shortcuts on the critical path to market: US FDA perspectives from the diagnostic side. Pharmacogenomics 2006;7(8):1223-7
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Guidance for Industry: pharmacogenomic data submissions. 2005
   Google Scholar
• Frueh FW. Impact of microarray data quality on genomic data submissions to the FDA. Nat Biotechnol 2006;24(9):1105-7
   PubMed Web of Science ®Google Scholar
• Bammler T, Beyer RP, Bhattacharya S, et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2005;2(5):351-6
   PubMed Web of Science ®Google Scholar
• Shi L, Reid LH, Jones WD, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006;24(9):1151-61
   PubMed Web of Science ®Google Scholar
• Beyer RP, Fry RC, Lasarev MR, et al. Multicenter study of acetaminophen hepatotoxicity reveals the importance of biological endpoints in genomic analyses. Toxicol Sci 2007;99(1):326-37
   PubMed Web of Science ®Google Scholar
• Ishkanian AS, Malloff CA, Watson SK, et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004;36(3):299-303
   PubMed Web of Science ®Google Scholar
• Arcellana-Panlilio M, Robbins SM. Cutting-edge technology. I. Global gene expression profiling using DNA microarrays. Am J Physiol Gastrointest Liver Physiol 2002;282(3):G397-402
   PubMed Web of Science ®Google Scholar
• Paules R. Phenotypic anchoring: linking cause and effect. Environ Health Perspect 2003;111(6):A338-9
   PubMed Web of Science ®Google Scholar
• Powell CL, Kosyk O, Ross PK, et al. Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol Sci 2006;93(1):213-22
   PubMed Web of Science ®Google Scholar
• Heinloth AN, Irwin RD, Boorman GA, et al. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol Sci 2004;80(1):193-202
   PubMed Web of Science ®Google Scholar
• Wang EJ, Snyder RD, Fielden MR, et al. Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology 2008;246(2-3):91-100
   PubMed Web of Science ®Google Scholar
• Khor TO, Ibrahim S, Kong AN. Toxicogenomics in drug discovery and drug development: potential applications and future challenges. Pharm Res 2006;23(8):1659-64
   PubMed Web of Science ®Google Scholar
• Ridd K, Zhang SD, Edwards RE, et al. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. Carcinogenesis 2006;27(8):1556-66
   PubMed Web of Science ®Google Scholar
• Christians U, Schmitz V, Schoning W, et al. Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges. Ther Drug Monit 2008;30(2):151-8
   PubMed Web of Science ®Google Scholar
• Bushel PR, Heinloth AN, Li J, et al. Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci USA 2007;104(46):18211-6
   PubMed Web of Science ®Google Scholar
• Burczynski ME, McMillian M, Ciervo J, et al. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol Sci 2000;58(2):399-415
   PubMed Web of Science ®Google Scholar
• Waring JF, Ulrich RG, Flint N, et al. Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. Environ Health Perspect 2004;112(4):439-48
   PubMed Web of Science ®Google Scholar
• Hamadeh HK, Bushel PR, Jayadev S, et al. Gene expression analysis reveals chemical-specific profiles. Toxicol Sci 2002;67(2):219-31
   PubMed Web of Science ®Google Scholar
• Inadera H, Tachibana S, Takasaki I, et al. Expression profile of liver genes in response to hepatotoxicants identified using a SAGE-based customized DNA microarray system. Toxicol Lett 2008;177(1):20-30
   PubMed Web of Science ®Google Scholar
• Dai X, He YD, Dai H, et al. Development of an approach for ab initio estimation of compound-induced liver injury based on global gene transcriptional profiles. Genome Inform 2006;17(2):77-88
   PubMedGoogle Scholar
• Fielden MR, Brennan R, Gollub J. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol Sci 2007;99(1):90-100
   PubMed Web of Science ®Google Scholar
• Eun JW, Ryu SY, Noh JH, et al. Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis. Toxicology 2008;249(2-3):176-83
   PubMed Web of Science ®Google Scholar
• Bartosiewicz MJ, Jenkins D, Penn S, et al. Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants. J Pharmacol Exp Ther 2001;297(3):895-905
   PubMed Web of Science ®Google Scholar
• McMillian M, Nie AY, Parker JB, et al. Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem Pharmacol 2004;67(11):2141-65
   PubMed Web of Science ®Google Scholar
• Harries HM, Fletcher ST, Duggan CM, Baker VA. The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol In Vitro 2001;15(4-5):399-405
   PubMed Web of Science ®Google Scholar
• Uehara T, Kiyosawa N, Shimizu T, et al. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans. Hum Exp Toxicol 2008;27(1):23-35
   PubMed Web of Science ®Google Scholar
• Elferink MG, Olinga P, Draaisma AL, et al. Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity. Toxicol Appl Pharmacol 2008;229(3):300-9
   PubMed Web of Science ®Google Scholar
• Lerche-Langrand C, Toutain HJ. Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 2000;153(1-3):221-53
   PubMed Web of Science ®Google Scholar
• Adachi Y, Bradford BU, Gao W, et al. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994;20(2):453-60
   PubMed Web of Science ®Google Scholar
• Wheeler MD, Kono H, Yin M, et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001;31(12):1544-9
   PubMed Web of Science ®Google Scholar
• Kumagai K, Kiyosawa N, Ito K, et al. Influence of Kupffer cell inactivation on cycloheximide-induced hepatic injury. Toxicology 2007;241(3):106-18
   PubMed Web of Science ®Google Scholar
• Andres D, Sanchez-Reus I, Bautista M, Cascales M. Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity. Expression of metallothionein and HSP70. Biochem Pharmacol 2003;66(6):917-26
   PubMed Web of Science ®Google Scholar
• Ito Y, Bethea NW, Abril ER, McCuskey RS. Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation 2003;10(5):391-400
   PubMed Web of Science ®Google Scholar
• National Research Council. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC: National Academies Press. 2007
   Google Scholar
• Gene Ontology. Available from: www.geneontology.org
   Google Scholar
• Gene Map Annotator and Pathway Profiler. Available from: www.genmapp.org
   Google Scholar
• Science Signaling Connections Map. Available from: stke.sciencemag.org/cm
   Google Scholar
• BioCarta. Available from: www.biocarta.com/genes/index.asp
   Google Scholar
• Reactome. Available from: www.genomeknowledge.org
   Google Scholar
• KEGG. Available from: www.genome.jp/kegg/pathway.html
   Google Scholar
• Zeeberg BR, Feng W, Wang G, et al. GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol 2003;4(4):R28
   PubMed Web of Science ®Google Scholar
• Barry WT, Nobel AB, Wright FA. Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 2005;21(9):1943-9
   PubMed Web of Science ®Google Scholar
• Khatri P, Bhavsar P, Bawa G, Draghici S. Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments. Nucleic Acids Res 2004;32(Web Server issue):W449-56
   PubMed Web of Science ®Google Scholar
• Burns JJ. IV. Pharmacogenetics and drug toxicity. Variation of drug metabolism in animals and the prediction of drug action in man. Ann N Y Acad Sci 1968;151(2):959-67
   PubMed Web of Science ®Google Scholar
• Kalow W. Contribution of hereditary factors to the response to drugs. Fed Proc 1965;24(6):1259-65
   PubMedGoogle Scholar
• Vesell ES, Page JG. Genetic control of dicumarol levels in man. J Clin Invest 1968;47(12):2657-63
   PubMed Web of Science ®Google Scholar
• Nebert DW, Zhang G, Vesell ES. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 2008;40(2):187-224
   PubMed Web of Science ®Google Scholar
• Cacabelos R. Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease. Mol Diagn Ther 2007;11(6):385-405
   PubMed Web of Science ®Google Scholar
• Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997;126(8):608-14
   PubMed Web of Science ®Google Scholar
• Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 1999;91(23):2001-8
   PubMed Web of Science ®Google Scholar
• Rost S, Fregin A, Ivaskevicius V, et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004;427(6974):537-41
   PubMed Web of Science ®Google Scholar
• Higashi MK, Veenstra DL, Kondo LM, et al. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. J Am Med Assoc 2002;287(13):1690-8
   PubMed Web of Science ®Google Scholar
• Rieder MJ, Reiner AP, Gage BF, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005;352(22):2285-93
   PubMed Web of Science ®Google Scholar
• Weinshilboum RM, Wang L. Pharmacogenetics and pharmacogenomics: development, science, and translation. Annu Rev Genomics Hum Genet 2006;7:223-45
   PubMed Web of Science ®Google Scholar
• Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291(5507):1304-51
   PubMed Web of Science ®Google Scholar
• Weiss ST, McLeod HL, Flockhart DA, et al. Creating and evaluating genetic tests predictive of drug response. Nat Rev Drug Discov 2008;7(7):568-74
   PubMed Web of Science ®Google Scholar
• Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008;358(6):568-79
   PubMed Web of Science ®Google Scholar
• Nebert DW, Vesell ES. Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead. Eur J Pharmacol 2004;500(1-3):267-80
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003;361(9357):567-71
   PubMed Web of Science ®Google Scholar
• Ntzani EE, Rizos EC, Ioannidis JP. Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. Am J Epidemiol 2007;165(9):973-84
   PubMed Web of Science ®Google Scholar
• Lesnick TG, Papapetropoulos S, Mash DC, et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007;3(6):e98
   PubMed Web of Science ®Google Scholar
• Donfack J, Buchinsky FJ, Post JC, Ehrlich GD. Human susceptibility to viral infection: the search for HIV-protective alleles among Africans by means of genome-wide studies. AIDS Res Hum Retroviruses 2006;22(10):925-30
   PubMed Web of Science ®Google Scholar
• McClurg P, Pletcher MT, Wiltshire T, Su AI. Comparative analysis of haplotype association mapping algorithms. BMC Bioinformatics 2006;7:61
   PubMed Web of Science ®Google Scholar
• Frazer KA, Eskin E, Kang HM, et al. A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature 2007;448(7157):1050-3
   PubMed Web of Science ®Google Scholar
• Pletcher MT, McClurg P, Batalov S, et al. Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol 2004;2(12):e393
   PubMedGoogle Scholar
• Guo Y, Weller P, Farrell E, et al. In silico pharmacogenetics of warfarin metabolism. Nat Biotechnol 2006;24(5):531-6
   PubMed Web of Science ®Google Scholar
• Guo Y, Lu P, Farrell E, et al. In silico and in vitro pharmacogenetic analysis in mice. Proc Natl Acad Sci USA 2007;104(45):17735-40
   PubMed Web of Science ®Google Scholar
• Churchill GA, Airey DC, Allayee H, et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat Genet 2004;36(11):1133-7
   PubMed Web of Science ®Google Scholar
• Roberts A, Pardo-Manuel de Villena F, Wang W, et al. The polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems genetics. Mamm Genome 2007;18(6-7):473-81
   PubMed Web of Science ®Google Scholar
• Wang K, Li M, Bucan M. Pathway-Based Approaches for Analysis of Genomewide Association Studies. Am J Hum Genet 2007;81(6)
   Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102(43):15545-50
   PubMed Web of Science ®Google Scholar
• Collison M, Glazier AM, Graham D, et al. Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes 2000;49(12):2222-6
   PubMed Web of Science ®Google Scholar
• Karp CL, Grupe A, Schadt E, et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat Immunol 2000;1(3):221-6
   PubMed Web of Science ®Google Scholar
• Hitzemann R, Reed C, Malmanger B, et al. On the integration of alcohol-related quantitative trait loci and gene expression analyses. Alcohol Clin Exp Res 2004;28(10):1437-48
   PubMed Web of Science ®Google Scholar
• Cook DN, Wang S, Wang Y, et al. Genetic regulation of endotoxin-induced airway disease. Genomics 2004;83(6):961-9
   PubMed Web of Science ®Google Scholar
• Chesler EJ, Lu L, Shou S, et al. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet 2005;37(3):233-42
   PubMed Web of Science ®Google Scholar
• Nebert DW, Jorge-Nebert L, Vesell ES. Pharmacogenomics and “individualized drug therapy”: high expectations and disappointing achievements. Am J Pharmacogenomics 2003;3(6):361-70
   PubMedGoogle Scholar
• Phipps AN, Stewart J, Wright B, Wilson ID. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 1998;28(5):527-37
   PubMed Web of Science ®Google Scholar
• Schrattenholz A, Soskic V. What does systems biology mean for drug development? Curr Med Chem 2008;15(15):1520-8
   PubMed Web of Science ®Google Scholar
• Thomas CE, Ganji G. Integration of genomic and metabonomic data in systems biology-are we ‘there’ yet? Curr Opin Drug Discov Devel 2006;9(1):92-100
   PubMed Web of Science ®Google Scholar
• Ippolito JE, Xu J, Jain S, et al. An integrated functional genomics and metabolomics approach for defining poor prognosis in human neuroendocrine cancers. Proc Natl Acad Sci USA 2005;102(28):9901-6
   PubMed Web of Science ®Google Scholar
• Li Z, Srivastava S, Mittal S, et al. A Three Stage Integrative Pathway Search (TIPS) framework to identify toxicity relevant genes and pathways. BMC Bioinformatics 2007;8:202
   PubMed Web of Science ®Google Scholar
• Verhoeckx KC, Bijlsma S, de Groene EM, et al. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 2004;4(4):1014-28
   PubMed Web of Science ®Google Scholar
• Hirai MY, Klein M, Fujikawa Y, et al. Elucidation of gene-to-gene and metabolite-to-gene networks in arabidopsis by integration of metabolomics and transcriptomics. J Biol Chem 2005;280(27):25590-5
   PubMed Web of Science ®Google Scholar
• Clayton TA, Lindon JC, Cloarec O, et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006;440(7087):1073-7
   PubMed Web of Science ®Google Scholar
• Comparative Toxicogenomics Database. Available from: ctd.mdibl.org
   Google Scholar
• Distributed Structure-Searchable Toxicity Database. Available from: www.epa.gov/ncct/dsstox/index.html
   Google Scholar
• Critical Path Institute. Available from: www.c-path.org
   Google Scholar
• Genelogic Database. Available from: www.genelogic.com
   Google Scholar
• Iconix Pharmaceuticals Database. Available from: www.iconixbiosciences.com
   Google Scholar
• Ceetox Database. Available from: www.ceetox.com
   Google Scholar
• Fostel JM. Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery. Pharmacogenomics 2007;8(5):425-30
   PubMed Web of Science ®Google Scholar
• Yang L, Allen BC, Thomas RS. BMDExpress: a software tool for the benchmark dose analyses of genomic data. BMC Genomics 2007;8:387
   PubMed Web of Science ®Google Scholar
• Chesler EJ, Miller DR, Branstetter LR, et al. The Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems genetics. Mamm Genome In Press
   Google Scholar